The medicine sector in India presents a intricate landscape, increasingly marked by concerns surrounding dominance . While the nation boasts a vibrant generic market, a few major companies maintain a disproportionate portion of the business , raising questions about competition and patient access to affordable medication . This situation is fueled

The pharmaceutical landscape in the nation is increasingly characterized by a appearance toward market concentration, with a handful of prominent companies wielding significant power. These industry giants, often bolstered by established distribution networks and strong brand recognition, present a difficult picture for competition and accessible h

Pharmaceutical pricing in India has long been a complex issue, with concerns about the affordability of essential medicines for the vast population. For years, several multinational pharmaceutical companies have held considerable sway over the market, effectively creating monopolies that often result in exorbitant drug prices. This situation prese

Pharmaceutical pricing in India has long been a complex issue, with concerns about the affordability of essential medicines for the vast population. For years, several multinational pharmaceutical companies have held considerable sway over the market, effectively establishing monopolies that often result in exorbitant drug prices. This situation p

Pharmaceutical pricing in India has long been a debated issue, with concerns about the affordability of essential medicines for the vast population. For years, several multinational pharmaceutical companies have held considerable sway over the market, effectively forming monopolies that often result in exorbitant drug prices. This situation presen